Skip to content

A Study on the Central Regulatory Mechanism of Tongue Edge Pricking in the Treatment of Post-stroke Dysphagia Based on Multi-modal fNIRS Technology

A Study on the Central Regulatory Mechanism of Tongue Edge Pricking in the Treatment of Post-stroke Dysphagia Based on Multi-modal fNIRS Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000771
Enrollment
Unknown
Registered
2026-03-27
Start date
2026-03-30
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke Dysphagia

Interventions

Tongue Edge Pricking Group:Acupuncture at the edge of the tongue puncture points
Fake Tongue Edge Pricking Group:Placebo needles at the edge of the tongue puncture points

Sponsors

General Hospital of the Western Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Stroke patients who meet the diagnostic criteria in the research protocol; (2) Age 18-80 years old, with no gender restrictions; (3) Disease duration of 1-12 months; (4) Patients are conscious with a Glasgow Coma Scale score of =12; (5) No oral mucosa or pharyngeal lesions; (6) A score of >2 on the (Wada Drinking Test); (7) Able to sit independently or with assistance for 40 minutes.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the inclusion criteria in the research protocol; (2) Those with structural oral, pharyngeal or esophageal diseases that affect swallowing function; (3) Those with consciousness disorders, tracheotomy or unstable vital signs; (4) Those with severe mental illness or severe cognitive impairment; (5) Those with severe underlying diseases and complications; (6) Those with concurrent diseases such as encephalitis, multiple sclerosis, amyotrophic lateral sclerosis, motor neuron disease, poliomyelitis, Guillain-Barré syndrome, myasthenia gravis or myopathy, and Alzheimer's disease; (7) Pregnant women and those in the lactation period.

Design outcomes

Primary

MeasureTime frame
FOIS(Functional Oral Intake Scale);

Secondary

MeasureTime frame
PAS(Penetration-Aspiration Scale);functional near-infrared spectroscopy;Modified Rankin Scale(mRS);Kubota Water Swallow Test(KWST);

Countries

China

Contacts

Public ContactLiu jiancheng

General Hospital of the Western Theater Command

422327057@qq.com+86 134 0808 3996

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026